Mesenchymal stromal cells and interferon α (IFNα) in cancer immunotherapy

被引：3
|
作者：
Saleiro, Diana [1 ,2 ]
Radecki, Sara G. [1 ,2 ]
Platanias, Leonidas C. [1 ,2 ,3 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[3] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
STEM-CELLS; ADAPTIVE IMMUNITY; TUMOR STROMA; MECHANISMS; MALIGNANCY; RESISTANCE; GAMMA;
D O I：
10.21037/tcr.2016.11.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1039 / S1043
页数：5
相关论文
共 50 条
  • [11] INTERFERON-α-ENGINEERED MULTIPOTENT MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF MYELOMA
    Tinelli, M.
    Mazzocco, M.
    Martini, M.
    Mosna, F.
    Lisi, V.
    Indraccolo, S.
    Moserle, L.
    Cestari, T.
    Riviera, A. P.
    Bifari, F.
    Tridente, G.
    Pizzolo, G.
    Sartoris, S.
    Krampera, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 304 - 304
  • [12] Effect of priming of multipotent mesenchymal stromal cells with interferon γ on their immunomodulating properties
    Kapranov, N. M.
    Davydova, Y. O.
    Galtseva, I. V.
    Petinati, N. A.
    Drize, N. I.
    Kuzmina, L. A.
    Parovichnikova, E. N.
    Savchenko, V. G.
    BIOCHEMISTRY-MOSCOW, 2017, 82 (10) : 1158 - 1168
  • [13] Effect of priming of multipotent mesenchymal stromal cells with interferon γ on their immunomodulating properties
    N. M. Kapranov
    Y. O. Davydova
    I. V. Galtseva
    N. A. Petinati
    N. I. Drize
    L. A. Kuzmina
    E. N. Parovichnikova
    V. G. Savchenko
    Biochemistry (Moscow), 2017, 82 : 1158 - 1168
  • [14] The Role of Mesenchymal Stem Cells in Cancer Immunotherapy
    Zhao, Yueshui
    Zhong, Xianmei
    Du, Fukuan
    Wu, Xu
    Li, Mingxing
    Wen, Qinglian
    Shen, Jing
    Chen, Yu
    Zhang, Xinyi
    Yang, Zhongming
    Deng, Ying
    Liu, Xiang
    Zou, Chang
    Du, Yu
    Xiao, Zhangang
    CURRENT STEM CELL RESEARCH & THERAPY, 2023, 18 (08) : 1056 - 1068
  • [15] Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming
    Chinnadurai, Raghavan
    Rajan, Devi
    Ng, Spencer
    McCullough, Kenneth
    Arafat, Dalia
    Waller, Edmund K.
    Anderson, Larry J.
    Gibson, Greg
    Galipeau, Jacques
    BLOOD ADVANCES, 2017, 1 (11) : 628 - 643
  • [16] Interferon Gamma and T Cells Inhibit Osteogenesis Induced by Allogeneic Mesenchymal Stromal Cells
    Dighe, Abhijit S.
    Yang, Scott
    Madhu, Vedavathi
    Balian, Gary
    Cui, Quanjun
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2013, 31 (02) : 227 - 234
  • [17] The effect of mesenchymal stromal cells in the microenvironment on cancer development
    Saglam-Ucar, Ozlem
    Degirmenci, Irfan
    Halbutogullari, Zehra Seda
    Posteki, Gokhan
    Subasi-Demirci, Cansu
    Erman, Gulay
    Karaoz, Erdal
    Utkan, N. Zafer
    MEDICAL ONCOLOGY, 2022, 39 (08)
  • [18] Genetically modified mesenchymal stromal cells in cancer therapy
    Sage, Elizabeth K.
    Thakrar, Ricky M.
    Janes, Sam M.
    CYTOTHERAPY, 2016, 18 (11) : 1435 - 1445
  • [19] Engineered mesenchymal stem/stromal cells against cancer
    Shi, Yuzhu
    Zhang, Jia
    Li, Yanan
    Feng, Chao
    Shao, Changshun
    Shi, Yufang
    Fang, Jiankai
    CELL DEATH & DISEASE, 2025, 16 (01):
  • [20] Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells
    Karl-Henrik Grinnemo
    Marie Löfling
    Lubov Nathanson
    Roland Baumgartner
    Daniel F. J. Ketelhuth
    Vladimir Beljanski
    Lindsay C. Davies
    Cecilia Österholm
    Stem Cell Research & Therapy, 10
12345